Fundz

Dexcel Pharma USA Appoints Daniel Connell as Chief Financial Officer

PRIVATEAug 01, 2026

Position

Chief Financial Officer

Company

Dexcel Pharma USA

Daniel Connell
New JerseyManufacturingBiotechnologyPharmaceutical

Description

Dexcel Pharma USA has strengthened its executive leadership team by appointing Daniel Connell as Senior Vice President & Chief Financial Officer. Connell will lead the company's financial strategy and support its continued growth in the specialty pharmaceutical market.

Quick answer

Dexcel Pharma USA Appoints Daniel Connell as Chief Financial Officer (August 1, 2026). Dexcel Pharma USA is based in New Jersey, United States.

Who is the new Chief Financial Officer at Dexcel Pharma USA?
Dexcel Pharma USA named Daniel Connell Chief Financial Officer, announced August 1, 2026.
What did Dexcel Pharma USA announce on August 1, 2026?
Dexcel Pharma USA has strengthened its executive leadership team by appointing Daniel Connell as Senior Vice President & Chief Financial Officer. Connell will lead the company's financial strategy and support its continued growth in the specialty pharmaceutical market.
What does Dexcel Pharma USA do?
Dexcel Pharma USA is the U.S. subsidiary of Dexcel Pharma, the largest private pharmaceutical company in Israel.
Where is Dexcel Pharma USA based?
Dexcel Pharma USA is based in New Jersey, United States.
Which similar companies made leadership changes around the same time?
Shilpa Medicare Limited (August 3, 2026), Helus Pharma (August 3, 2026), Cipla (July 23, 2026) and FAMAR Group (July 23, 2026) also announced leadership changes within 45 days of Dexcel Pharma USA.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Dexcel Pharma USA, and when

A new leader at Dexcel Pharma USA brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Dexcel Pharma USA raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dexcel Pharma USA, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dexcel Pharma USA. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Dexcel Pharma USA

Location

New Jersey, United States

About

Dexcel Pharma USA is the U.S. subsidiary of Dexcel Pharma, the largest private pharmaceutical company in Israel. It commercializes an extensive portfolio of branded and generic drugs. The company focuses on developing and manufacturing high-quality products. It also strives to maintain long-term partnerships across the value chain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Dexcel Pharma USA changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Douglas
Senior decision-maker at this company
••••••••@••••••••

See Douglas's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Dexcel Pharma USA's next move

Learn about Strategic plan

Dexcel Pharma USA changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.